Search Within

Jaclyn Frances Hechtman

  1. "Donavan Cheng"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  2. Department of Pathology and Laboratory Medicine (6)
  3. GSK Faculty (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Tow Center for Developmental Oncology (TCDO) (6)
  6. Department of Medicine (5)

More Groups

People
  1. Ahmet Zehir (6)
  2. Donavan Cheng (6)
  3. Marc Ladanyi (6)
  4. Maria Arcila (6)
  5. Michael Berger (6)
  6. David Hyman (5)

More People

Years
  1. 2017 (2)
  2. 2015 (4)
Publications
  1. Journal of Molecular Diagnostics (2)
  2. Journal of Clinical Oncology (1)
  3. Laboratory Investigation (1)
  4. Modern Pathology (1)
  5. Nature Medicine (1)
Publishers
  1. Elsevier Science, Inc. (2)
  2. Nature Publishing Group (2)
  3. American Society of Clinical Oncology (1)
  4. Nature Research (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay
    Journal Article

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
    Journal Article

    Cheng, D. T.; Mitchell, T. N.; Zehir, A.; Shah, R. H.; Benayed, R.; Syed, A.; Chandramohan, R.; Liu, Z. Y.; Won, H. H.; Scott, S. N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J. R.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save